MEETINGS - Technology Acquisition: The Impact of Clinical Trials (US) October 1998:
This article was originally published in Clinica
The Association for the Advancement of Medical Instrumentation will hold a meeting entitled Technology Acquisition: The Impact of Clinical Trials on October 9-10 in Baltimore. Representatives from the Health Care Financing Administration, the FDA and industry will discuss topics such as requirements for clinical trial design and outcomes; interpretation of safety and effectiveness in premarket approval process; and new guidelines for premarket approval of Class III devices by means of a product development protocol. The government's views on technology assessment and clinical trials will also be presented. Delegates will be able to participate in a mock clinical trial developed by the FDA to train its reviewers. For more information contact AAMI in the US. Fax: +1 703 525 1424.
You may also be interested in...
HAL Allergy Group, developer of products for allergy diagnostics and allergen immunotherapy, promoted its principal scientist to chief R&D officer; Starkey Hearing Technologies brought on new health and business development execs to expand its global footprint; and more.
As the coronavirus continues to spread, one of the big four global vaccines companies has committed itself to the fight.